Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1992 1
1993 3
1995 2
1997 1
1998 2
1999 2
2000 2
2001 3
2002 1
2004 1
2005 1
2006 1
2007 1
2008 1
2009 2
2010 8
2011 4
2012 3
2013 4
2014 4
2015 8
2016 11
2017 5
2018 13
2019 14
2020 7
2021 9
2022 10
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Randomized Trial of Fetal Surgery for Severe Left Diaphragmatic Hernia.
Deprest JA, Nicolaides KH, Benachi A, Gratacos E, Ryan G, Persico N, Sago H, Johnson A, Wielgoś M, Berg C, Van Calster B, Russo FM; TOTAL Trial for Severe Hypoplasia Investigators. Deprest JA, et al. N Engl J Med. 2021 Jul 8;385(2):107-118. doi: 10.1056/NEJMoa2027030. Epub 2021 Jun 8. N Engl J Med. 2021. PMID: 34106556 Free PMC article. Clinical Trial.
High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo.
Huayamares SG, Lokugamage MP, Rab R, Da Silva Sanchez AJ, Kim H, Radmand A, Loughrey D, Lian L, Hou Y, Achyut BR, Ehrhardt A, Hong JS, Sago CD, Paunovska K, Echeverri ES, Vanover D, Santangelo PJ, Sorscher EJ, Dahlman JE. Huayamares SG, et al. J Control Release. 2023 May;357:394-403. doi: 10.1016/j.jconrel.2023.04.005. Epub 2023 Apr 12. J Control Release. 2023. PMID: 37028451 Free PMC article.
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, Pais P, López-Jaramillo P, Leiter LA, Dans A, Avezum A, Piegas LS, Parkhomenko A, Keltai K, Keltai M, Sliwa K, Peters RJ, Held C, Chazova I, Yusoff K, Lewis BS, Jansky P, Khunti K, Toff WD, Reid CM, Varigos J, Sanchez-Vallejo G, McKelvie R, Pogue J, Jung H, Gao P, Diaz R, Lonn E; HOPE-3 Investigators. Yusuf S, et al. N Engl J Med. 2016 May 26;374(21):2021-31. doi: 10.1056/NEJMoa1600176. Epub 2016 Apr 2. N Engl J Med. 2016. PMID: 27040132 Free article. Clinical Trial.
The Many Hosts of Mycobacteria 9 (MHM9): A conference report.
Klever AM, Alexander KA, Almeida D, Anderson MZ, Ball RL, Beamer G, Boggiatto P, Buikstra JE, Chandler B, Claeys TA, Concha AE, Converse PJ, Derbyshire KM, Dobos KM, Dupnik KM, Endsley JJ, Endsley MA, Fennelly K, Franco-Paredes C, Hagge DA, Hall-Stoodley L, Hayes D Jr, Hirschfeld K, Hofman CA, Honda JR, Hull NM, Kramnik I, Lacourciere K, Lahiri R, Lamont EA, Larsen MH, Lemaire T, Lesellier S, Lee NR, Lowry CA, Mahfooz NS, McMichael TM, Merling MR, Miller MA, Nagajyothi JF, Nelson E, Nuermberger EL, Pena MT, Perea C, Podell BK, Pyle CJ, Quinn FD, Rajaram MVS, Mejia OR, Rothoff M, Sago SA, Salvador LCM, Simonson AW, Spencer JS, Sreevatsan S, Subbian S, Sunstrum J, Tobin DM, Vijayan KKV, Wright CTO, Robinson RT. Klever AM, et al. Tuberculosis (Edinb). 2023 Sep;142:102377. doi: 10.1016/j.tube.2023.102377. Epub 2023 Jul 23. Tuberculosis (Edinb). 2023. PMID: 37531864 Review.
Using Large Datasets to Understand Nanotechnology.
Paunovska K, Loughrey D, Sago CD, Langer R, Dahlman JE. Paunovska K, et al. Adv Mater. 2019 Oct;31(43):e1902798. doi: 10.1002/adma.201902798. Epub 2019 Aug 20. Adv Mater. 2019. PMID: 31429126 Free PMC article. Review.
Postprandial glucose-lowering effects by sago (Metroxylon sagu Rottb.) resistant starch in spontaneously type 2 diabetes, Goto-Kakizaki rat.
Lokman EF, Bugam SH, Ibrahim AS, Yunus N, Mansor F, Balasubramaniam V, Mohamad KM, Md Lazim R, Awang Seruji AZR. Lokman EF, et al. Nutr Health. 2023 Feb 8:2601060231152060. doi: 10.1177/02601060231152060. Online ahead of print. Nutr Health. 2023. PMID: 36755355 Free article.
Introduction: The beneficial effects of resistant starch (RS) consumption on health in terms of reducing postprandial hyperglycaemia are evident. However, the potential of local Sarawak sago RS in regulating glucose has not been extensively studied. Objectives: This study …
Introduction: The beneficial effects of resistant starch (RS) consumption on health in terms of reducing postprandial hyperglycaemia are evi …
Physiologic and performance effects of sago supplementation before and during cycling in a warm-humid environment.
Che Jusoh MR, Stannard SR, Mündel T. Che Jusoh MR, et al. Temperature (Austin). 2016 Mar 3;3(2):318-327. doi: 10.1080/23328940.2016.1159772. eCollection 2016 Apr-Jun. Temperature (Austin). 2016. PMID: 27857961 Free PMC article.
The present study determined whether 0.8g/kg bodyweight sago ingested before (Pre-Sago) or during (Dur-Sago) exercise under warm-humid conditions (30 2C, 78 3 % RH; 20 km.h(-1) frontal airflow) conferred a performance and/or physiological benefit compa …
The present study determined whether 0.8g/kg bodyweight sago ingested before (Pre-Sago) or during (Dur-Sago) exercise u …
Synthesis and characterization of sago starch nanocrystal laurate as a food grade particle emulsifier.
Ahmad A, Fazial FF, Khalil HPSA, Fazry S, Lazim A. Ahmad A, et al. Int J Biol Macromol. 2023 Jul 1;242(Pt 2):124816. doi: 10.1016/j.ijbiomac.2023.124816. Epub 2023 May 12. Int J Biol Macromol. 2023. PMID: 37182623
Starch nanocrystals (SNCs) are tiny particles that possess unique qualities due to their small size, such as increased crystallinity, thin sheet structure, low permeability, and strong resistance to digestion. Although sago starch nanocrystals (SNCs) are naturally hydrophi …
Starch nanocrystals (SNCs) are tiny particles that possess unique qualities due to their small size, such as increased crystallinity, thin s …
Investigation of dual modification on physicochemical, morphological, thermal, pasting, and retrogradation characteristics of sago starch.
Ghalambor P, Asadi G, Mohammadi Nafchi A, Seyedin Ardebili SM. Ghalambor P, et al. Food Sci Nutr. 2022 Mar 24;10(7):2285-2299. doi: 10.1002/fsn3.2837. eCollection 2022 Jul. Food Sci Nutr. 2022. PMID: 35844929 Free PMC article.
The aim of this study was to evaluate the characteristics of dually modified sago starch by acid hydrolysis (AH)-hydroxypropylation (HP). For this purpose, sago starch was modified with the combination by AH (5-20 h hydrolysis times) followed by HP (5%-25% ra …
The aim of this study was to evaluate the characteristics of dually modified sago starch by acid hydrolysis (AH)-hydroxypropylation ( …
Microwave assisted acid hydrolysis for bioethanol fuel production from sago pith waste.
Thangavelu SK, Rajkumar T, Pandi DK, Ahmed AS, Ani FN. Thangavelu SK, et al. Waste Manag. 2019 Mar 1;86:80-86. doi: 10.1016/j.wasman.2019.01.035. Epub 2019 Jan 28. Waste Manag. 2019. PMID: 30902242
Microwave assisted acid hydrolysis (H(2)SO(4) and HCl with >0.5 mol/L) to produce bioethanol from sago pith waste (SPW) was studied. ...A maximum of 88% glucose yield and 80% ethanol yield (3.1 g ethanol per 10 g SPW) were obtained using 1.0 mol/L H(2)SO(4 …
Microwave assisted acid hydrolysis (H(2)SO(4) and HCl with >0.5 mol/L) to produce bioethanol from sago pith waste (SPW) was …
115 results